View in EDS PDF Full Text

Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro.

Saved in:
Bibliographic Details
Title: Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro.
Authors: Gauhar A; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA., Privezentzev CV; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA., Demydchuk M; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA., Gerlza T; Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Graz, Austria., Rieger J; Institute of Pathology, Medical University Graz, Graz, Austria., Kungl AJ; Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Graz, Austria., Walsh FS; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA., Rutkowski JL; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA., Stocki P; Ossianix, Inc, Stevenage Bioscience Catalyst, Stevenage, UK.; Ossianix, Inc, Philadelphia, Pennsylvania, USA.
Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2021 Nov; Vol. 35 (11), pp. e21970.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-6860
DOI:10.1096/fj.202100986RR